Huaier extract restrains the proliferative potential of endocrine-resistant breast cancer cells through increased ATM by suppressing miR-203
Abstract Endocrine therapy is one of the main treatments for breast cancer patients in the early stages. Tamoxifen and fulvestrant are the major drugs of endocrine therapy for breast cancer patients. However, acquired drug resistance often caused treatment failure and relapse for patients, which is...
Guardado en:
Autores principales: | Sumei Gao, Xiaoyan Li, Xia Ding, Liyu Jiang, Qifeng Yang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eab71cee0273459bbcb763ec3ec32fda |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation.
por: Dan Yan, et al.
Publicado: (2010) -
ATM-dependent MiR-335 targets CtIP and modulates the DNA damage response.
por: Nathan T Martin, et al.
Publicado: (2013) -
The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells
por: Penn Muluhngwi, et al.
Publicado: (2017) -
Resolución 203(IX): Investigación tecnológica = Resolution 203(IX): Technological research = Résolution 203(IX): Recherche technique
Publicado: (2014) -
The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas.
por: Tali Avnit-Sagi, et al.
Publicado: (2009)